Cite
MLA Citation
A. Guida et al.. “2626 Efficacy and safety of axitinib as third line therapy in metastatic renal cell carcinoma (mRCC): Retrospective analysis.” European journal of cancer, vol. 51, n.d., pp. S521–. http://access.bl.uk/ark:/81055/vdc_100030628262.0x000063